457 related articles for article (PubMed ID: 21755828)
1. Validity of procalcitonin and C-reactive protein measurement when differentiating between benign and malignant pleural effusion.
Botana-Rial M; Casado-Rey P; Leiro-Fernández V; Andrade-Olivié M; Represas-Represas C; Fernández-Villar A
Clin Lab; 2011; 57(5-6):373-8. PubMed ID: 21755828
[TBL] [Abstract][Full Text] [Related]
2. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion.
Lee SH; Lee EJ; Min KH; Hur GY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Lee SY
Clin Biochem; 2013 Oct; 46(15):1484-8. PubMed ID: 23570862
[TBL] [Abstract][Full Text] [Related]
3. A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion.
Chierakul N; Kanitsap A; Chaiprasert A; Viriyataveekul R
Respirology; 2004 Mar; 9(1):66-9. PubMed ID: 14982604
[TBL] [Abstract][Full Text] [Related]
4. Pleural fluid and serum procalcitonin as diagnostic tools in tuberculous pleurisy.
Cakir E; Deniz O; Ozcan O; Tozkoparan E; Yaman H; Akgul EO; Bilgi C; Bilgic H; Ekiz K; Erbil MK
Clin Biochem; 2005 Mar; 38(3):234-8. PubMed ID: 15708544
[TBL] [Abstract][Full Text] [Related]
5. The use of pleural fluid procalcitonin and C-reactive protein in the diagnosis of parapneumonic pleural effusions: a systemic review and meta-analysis.
Zou MX; Zhou RR; Wu WJ; Zhang NJ; Liu WE; Fan XG
Am J Emerg Med; 2012 Nov; 30(9):1907-14. PubMed ID: 22795416
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
Dong J; Sun G; Zhu H
Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059
[TBL] [Abstract][Full Text] [Related]
7. Procalcitonin, C-reactive protein, and cell counts in the diagnosis of parapneumonic pleural effusions.
San José ME; Valdés L; Vizcaíno LH; Mora T; Pose A; Soneira E; Crecente C; González-Barcala FJ
J Investig Med; 2010 Dec; 58(8):971-6. PubMed ID: 20930646
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of procalcitonin in pleural effusions.
Wang CY; Hsiao YC; Jerng JS; Ho CC; Lai CC; Yu CJ; Hsueh PR; Yang PC
Eur J Clin Microbiol Infect Dis; 2011 Mar; 30(3):313-8. PubMed ID: 20938702
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic value of pleural fluid and serum procalcitonin levels in the diagnosis of parapneumonic pleural effusion].
Doğan C; Bilaçeroğlu S; Çirak AK; Özsöz A; Özbek D
Tuberk Toraks; 2013; 61(2):103-9. PubMed ID: 23875587
[TBL] [Abstract][Full Text] [Related]
10. The role of serum procalcitonin in establishing the diagnosis and prognosis of pleural infection.
Dixon G; Lama-Lopez A; Bintcliffe OJ; Morley AJ; Hooper CE; Maskell NA
Respir Res; 2017 Feb; 18(1):30. PubMed ID: 28158976
[TBL] [Abstract][Full Text] [Related]
11. [Contribution of pleural fluid analysis to the diagnosis of pleural effusion].
Ferreiro L; Toubes ME; Valdés L
Med Clin (Barc); 2015 Aug; 145(4):171-7. PubMed ID: 25433793
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of soluble B7-H4 and carcinoembryonic antigen in distinguishing malignant from benign pleural effusion.
Jing X; Wei F; Li J; Dai L; Wang X; Jia L; Wang H; An L; Yang Y; Zhang G; Cheng Z
Clin Respir J; 2018 Mar; 12(3):986-990. PubMed ID: 28127951
[TBL] [Abstract][Full Text] [Related]
13. Assessment of a panel of miRNAs in serum and pleural fluid for the differential diagnosis of malignant and benign pleural effusion.
Zhu LR; Yuan RX; Xia XB; Wang Y; Zhu YM; Fi L; Li J
Cancer Biomark; 2022; 33(1):71-82. PubMed ID: 34366325
[TBL] [Abstract][Full Text] [Related]
14. The usefulness of pleural fluid presepsin, C-reactive protein, and procalcitonin in distinguishing different causes of pleural effusions.
Watanabe N; Ishii T; Kita N; Kanaji N; Nakamura H; Nanki N; Ueda Y; Tojo Y; Kadowaki N; Bandoh S
BMC Pulm Med; 2018 Nov; 18(1):176. PubMed ID: 30470216
[TBL] [Abstract][Full Text] [Related]
15. Serum and pleural fluid procalcitonin in predicting bacterial infection in patients with parapneumonic effusion.
Ko YC; Wu WP; Hsu CS; Dai MP; Ou CC; Kao CH
J Korean Med Sci; 2009 Jun; 24(3):398-402. PubMed ID: 19543500
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Accuracy of Pleural Fluid Cytology, Carcinoembryonic Antigen and C-Reactive Protein Together in Patients With Pulmonary Metastases and Malignant Pleural Effusion.
Basso SMM; Del Conte A; Zuccon U; Sulfaro SC; Fanti G; Maffeis F; Ubiali P; Ermani M; Lumachi F
Anticancer Res; 2020 Oct; 40(10):5877-5881. PubMed ID: 32988918
[TBL] [Abstract][Full Text] [Related]
17. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
Wei F; Wei Y; Li LF; Li GL; Wang GJ
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
[No Abstract] [Full Text] [Related]
18. Differences in
Xie T; Wang Q; Gao J; He K; Yu J
Ann Clin Lab Sci; 2024 Mar; 54(2):201-210. PubMed ID: 38802158
[TBL] [Abstract][Full Text] [Related]
19. Pleural fluid mesothelin for the differential diagnosis of exudative pleural effusions.
Alemán C; Manuel Porcel J; Ma Segura R; Alegre J; Esquerda A; Ruiz E; Bielsa S; de Sevilla TF
Med Clin (Barc); 2009 Oct; 133(12):449-53. PubMed ID: 19783262
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Value of Six Tumor Markers for Malignant Pleural Effusion in 1,230 Patients: A Single-Center Retrospective Study.
Fan X; Liu Y; Liang Z; Wang S; Yang J; Wu A
Pathol Oncol Res; 2022; 28():1610280. PubMed ID: 35515016
[No Abstract] [Full Text] [Related]
[Next] [New Search]
